Ballhausen-Lübcker, Sabrina
Ruß, Anne-Kathrin
Lieb, Wolfgang
Schäfer, Anna
Krist, Lilian
Fricke, Julia
Scheibenbogen, Carmen
Rabe, Klaus F.
Maetzler, Walter
Maetzler, Corina
Laudien, Martin
Frank, Derk
Heyckendorf, Jan
Miljukov, Olga
Haeusler, Karl Georg
El Mokhtari, Nour Eddine
Witzenrath, Martin
Vehreschild, Jörg Janne
Appel, Katharina S.
Chaplinskaya-Sobol, Irina
Tamminga, Thalea
Nürnberger, Carolin
Schmidbauer, Lena
Morbach, Caroline
Störk, Stefan
Reese, Jens-Peter
Keil, Thomas
Heuschmann, Peter
Schreiber, Stefan
Krawczak, Michael
Bahmer, Thomas
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Article History
Received: 15 July 2024
Accepted: 10 July 2025
First Online: 26 August 2025
Declarations
:
: COVIDOM has been carried out in accordance with relevant guidelines and regulations. The study was approved by the local ethic committees of the university hospitals of Kiel (No. D 537/20) and Würzburg (No. 236/20_z). According to the professional code of the Berlin Medical Association, approval by the Kiel ethics committee was also valid for the Berlin study site. All participants provided written informed consent prior to their inclusion.The COVIDOM study was registered prospectively at clinicaltrials.gov (NCT04679584, first registered 2020-12-18) and the German Clinical Trials Register (DRKS, DRKS00023742).
: All authors approved the final version of the manuscript and its submission.
: The authors declare no competing interests.